Last reviewed: June 16, 2026
Last updated: June 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has transformed weight management for millions by activating GLP-1 receptors in the brain and pancreas, reducing hunger and improving blood sugar control. Understanding how dosing works helps patients make informed decisions about whether this medication aligns with their health goals. PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies, tailored to individual needs without flat per-compound pricing increases.
How Semaglutide Dosing Schedules Work in Clinical Practice
Semaglutide dosing follows a gradual titration protocol designed to help the body adjust and reduce gastrointestinal side effects. Most patients begin at 0.25 milligrams once weekly, a dose that activates GLP-1 pathways without overwhelming the system. Over four to eight weeks, doses increase incrementally—typically to 0.5 mg, then 1.0 mg, and potentially up to 2.4 mg weekly—based on individual tolerance and weight loss response.
This stepped approach allows prescribers to identify each patient's optimal therapeutic dose, the point where benefits plateau and further increases offer minimal additional weight loss. Clinical trials show that most patients achieve meaningful results between 1.0 and 2.4 mg weekly, though individual responses vary based on genetics, metabolism, and lifestyle factors. Starting low protects against nausea, vomiting, and appetite suppression that can feel overwhelming at higher initial doses.
Starting Dose Versus Maintenance: What the Research Shows
The starting dose of 0.25 mg semaglutide represents a deliberate clinical choice rather than a therapeutic dose. Research demonstrates that this introductory amount allows GLP-1 receptors to become sensitized while minimizing the likelihood of intolerable side effects that might cause patients to discontinue therapy. Patients typically remain at this dose for one to two weeks before advancing.
Maintenance doses—those producing sustained weight loss—typically range from 1.0 to 2.4 mg weekly in published trials. A landmark trial showed that participants at 2.4 mg weekly experienced approximately 15% body weight reduction over 68 weeks compared to placebo. However, not every patient requires the maximum dose; some achieve their goals at 1.0 or 1.5 mg, meaning PlexusDx's fixed monthly pricing prevents unexpected increases as your prescription advances through the titration schedule.
Personalizing Your Semaglutide Dose With Genetic Insights
Individual semaglutide response depends partly on inherited genetic variation in GLP-1 receptor sensitivity and related metabolic pathways. The GLP1R gene variant rs6923761 influences how efficiently semaglutide activates hunger-suppressing signals in the hypothalamus, potentially affecting the dose needed for optimal response. Patients carrying certain alleles may experience robust weight loss at lower doses, while others may require higher amounts to achieve comparable results.
PlexusDx's Precision Peptide Genetic Test examines 14 distinct pathways spanning 49 peptides and over 150 genetic insights, including variants in GLP1R, GIPR, FTO, and MC4R genes that predict individual semaglutide sensitivity. This $99 add-on test, available after your first month of treatment, maps your genetic predispositions to help your clinician refine dosing strategies and select complementary compounds if needed. Understanding your genetic profile transforms semaglutide from a one-size-fits-all approach into truly personalized precision medicine.
Side Effects and Dose Adjustment: Finding Your Sweet Spot
Gastrointestinal side effects—nausea, vomiting, constipation, and reduced appetite—intensify with higher semaglutide doses but typically diminish as the body acclimates over two to four weeks at each dose level. Slowing titration or pausing at a lower dose allows the digestive system to adjust while maintaining therapeutic benefit. Some patients never advance beyond 1.0 or 1.5 mg because they achieve their weight loss goals and tolerate side effects well at that level.
Serious adverse events, including pancreatitis and thyroid concerns, remain rare in clinical use but require medical monitoring. PlexusDx patients work with licensed clinicians who adjust doses based on tolerability, response, and medical history rather than applying rigid protocols. If nausea or vomiting becomes problematic, your provider may slow titration, decrease temporarily, or explore alternative formulations like oral semaglutide without changing your monthly cost.
PlexusDx Semaglutide Pricing: Your Dose Rises, Your Price Stays the Same
PlexusDx breaks from industry convention by charging a flat monthly rate for semaglutide regardless of which dose you're taking during titration or maintenance. Compounded semaglutide injections start at $149 monthly across three commitment tiers, meaning whether you begin at 0.25 mg or reach 2.4 mg, your price remains predictable. This transparent model eliminates the financial anxiety many patients experience when contemplating dose increases in traditional settings.
All PlexusDx medications come from licensed 503A compounding pharmacies serving all 50 states without requiring insurance or membership fees. Treatment plans are HSA and FSA eligible, and the optional Precision Peptide Genetic Test costs $99 after your first month. By removing financial barriers to optimal dosing, PlexusDx empowers patients to stay on their medication long enough to reach their weight loss targets rather than cutting corners because of escalating costs.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg injected subcutaneously once weekly. This introductory amount activates GLP-1 pathways while minimizing nausea and other side effects, typically for one to two weeks before advancement. PlexusDx patients begin at this dose regardless of their final target, with personalized adjustments guided by your clinician.
Is there a maximum effective dose of semaglutide?
Clinical trials support doses up to 2.4 mg weekly as the highest approved strength, producing approximately 15% average body weight loss. However, many patients achieve meaningful results at 1.0 or 1.5 mg weekly. Your optimal dose is the lowest amount producing your desired weight loss with tolerable side effects, determined through gradual titration and monitoring.
How long does it take to reach a therapeutic dose?
Typical titration requires four to eight weeks, advancing by 0.25 mg increments weekly or every two weeks depending on tolerability. Some patients pause at intermediate doses longer if side effects are bothersome or if they're already seeing weight loss progress. Your PlexusDx clinician tailors the schedule to your individual response.
Does PlexusDx charge more for higher semaglutide doses?
No. PlexusDx compounded semaglutide injections are priced at a flat $149 per month starting rate across three commitment tiers, regardless of your dose level. Your price won't increase as your dose goes up during titration or maintenance—only your dose changes, not your cost.
Can genetic testing help determine my ideal semaglutide dose?
Yes. PlexusDx's Precision Peptide Genetic Test analyzes GLP1R rs6923761 and related variants affecting semaglutide receptor sensitivity and metabolic response. For $99 after your first month, this test reveals genetic insights across 14 pathways and 49 peptides, enabling your clinician to predict dose requirements and potentially recommend complementary compounds for enhanced outcomes.
What happens if side effects are severe at my current dose?
Your PlexusDx clinician can pause advancement, reduce temporarily, or extend the time spent at your current dose to allow adaptation. Some patients switch to oral semaglutide or explore alternative GLP-1 compounds without price increases. The goal is finding the dose producing maximum benefit with side effects you can manage.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Help the Nausea from Ozempic and Stay on Track with Your Weight Loss Goals
Can I Take Ozempic While Breastfeeding? Navigating Weight Management and Nursing